Pharmacovigilance. On the Roadmap.
Pharmacovigilance runs under GVP. GVP is Phase 3 on the Verixa roadmap (2028+) — a planned module, not a live product today. Verixa Phase 1 covers GMP.
This page describes a roadmap commitment. Express interest to help shape the GVP module as an early founding partner.
What Teams Face Today
Safety Signal Overload
Struggling to separate critical safety signals from noise due to disjointed data systems.
Inefficient Case Processing
Manual intake and triage of adverse events leading to compliance delays.
Complex Regulatory Reporting
Aggregating data for periodic safety update reports (PSURs) takes massive manual effort.
Compliance Tracking
Difficulties tracking corrective actions for GVP audit findings across multiple stakeholder teams.
Where Verixa Is Headed
Integrated Signal Management
Planned for the GVP module: centralized workflows to track, validate, and escalate safety signals.
Structured Case Workflows
On the roadmap: intake and tracking designed to help teams meet regulatory timelines.
A Single Source for Safety Data
A roadmap goal: one source of truth for safety events to reduce report-preparation effort.
End-to-End Traceability
Targeted for the GVP module: electronic traceability from adverse-event intake through CAPA resolution, under 21 CFR Part 11-aligned controls.
Help Shape the GVP Module
GVP is a Phase 3 roadmap commitment (2028+), not a live module. Tell us about your pharmacovigilance operations to be considered for early design-partner participation.